Condition deep-dive · 5 min read

Burning Mouth Syndrome — supplement adjuncts after secondary causes ruled out

Updated 2026-05-13 · Reviewed by SupplementScore editors · No sponsorships

Burning Mouth Syndrome (BMS) is a chronic intraoral pain syndrome — most often a burning, scalding, or numb sensation of the tongue, lips, or oral mucosa — without identifiable visible lesions, most common in postmenopausal women. The "primary" or idiopathic form is a diagnosis of exclusion after ruling out "secondary BMS" caused by treatable conditions: nutritional deficiencies (B12, folate, iron, zinc), candidiasis, lichen planus, xerostomia, hypothyroidism, diabetes, medication side effects (ACEi, SSRIs), denture irritation, or oral parafunctions. Supplements have a genuine role when secondary BMS from deficiency is identified; alpha-lipoic acid has small-trial evidence as adjunct in primary BMS.

Read this first. Get the workup before assuming primary BMS. Visible oral lesions, ulcers, white patches, or symptoms confined to one anatomical site warrant dental/oral medicine evaluation to exclude candidiasis, lichen planus, geographic tongue, neoplasia. Nutritional bloodwork (CBC, ferritin, B12, folate, zinc) and screening for diabetes and thyroid disease are routine. Primary BMS is the diagnosis after these are excluded.

The supplement adjuncts — depend heavily on workup results

Tier 1 evidence · When deficiency is present

Iron, B12, folate, zinc — correct identified deficiencies

B12: methylcobalamin 1000 µg/day or appropriate replacement. Folate: 400–800 µg/day. Iron: alternate-day repletion if iron deficient. Zinc: 15–25 mg/day if low

"Secondary" BMS from these deficiencies is treatable — symptoms often resolve over weeks-to-months of repletion. Don't blindly stack these without bloodwork; supplementing without deficiency wastes time and money and obscures diagnosis.

Tier 2 evidence · For primary BMS (after deficiencies ruled out)

Alpha-lipoic acid (ALA)

600 mg/day oral (often 200 mg TID) for 2–3 months; allow 6+ weeks

Several small RCTs (Femiano 2002, 2004; Lopez-Jornet 2009) show modest BMS symptom improvement with ALA 600 mg/day over 8–12 weeks. Effect sizes are modest; a Cochrane review found insufficient evidence for routine recommendation but reasonable trial in primary BMS. Best evidence among supplements for primary BMS.

Tier 3 evidence · Adjunct for anxiety component

Magnesium glycinate and L-theanine

Magnesium glycinate 200 mg at bedtime; L-theanine 200 mg as needed for stress

Primary BMS commonly has anxiety, depression, and somatic-symptom-spectrum features. Addressing these reduces functional impact even when oral symptoms persist. CBT and SNRI/SSRI options under primary care or pain specialty are more direct.

Tier 3 evidence · For xerostomia component

Hydration, saliva substitutes, sialogogues

Frequent water sips; xylitol-containing lozenges; OTC saliva substitutes (Biotène, Oasis)

Many BMS users have subclinical xerostomia that amplifies symptoms. Review medications for xerostomia-inducing drugs (anticholinergics, antihistamines, antidepressants, antihypertensives). Sjögren screening if dry eye accompanies.

What to skip

"Oral pH balancing" supplements — gastric and salivary pH are not modifiable by oral supplements; commercial "pH balance" formulas are not BMS treatment.
Aggressive oral antifungals without confirmed candidiasis — empirical treatment without evidence of yeast can mask diagnosis.
Capsaicin-containing supplements internally — topical capsaicin oral rinses have some BMS evidence (densitisation paradigm) under dental/oral medicine supervision; oral capsaicin supplements aren't equivalent.
"Mouth healing" amino acid blends — without specific clinical evidence.
Cinnamon-flavoured supplements / mints / gum — common BMS trigger / amplifier.
SLS-containing toothpastes — sodium lauryl sulfate is a frequent BMS irritant; switch to SLS-free.

The clinical framework

Comprehensive workup — CBC, ferritin, B12, folate, zinc, fasting glucose / HbA1c, TSH, oral candidiasis evaluation, denture / dental assessment, medication review (ACEi, SSRIs, anticholinergics, antidiabetic agents).
Treat identified secondary causes — iron, B12, folate, zinc replacement if deficient; antifungal for candidiasis; medication adjustment under prescriber.
For primary BMS — clonazepam (oral dissolving tablet "swish and spit") under prescription has good evidence. Topical capsaicin under oral medicine guidance. Low-dose tricyclic antidepressants (nortriptyline, amitriptyline) or SNRIs for neuropathic component. CBT.
Oral hygiene optimisation — SLS-free toothpaste, avoid alcohol-containing mouthwashes, avoid known irritants (cinnamon, peppermint in some users, citrus, spicy foods).
Hydration and parafunction management — address mouth breathing, bruxism, denture fit if applicable.
Pain psychology / chronic pain management — BMS is chronic pain; multidisciplinary care helps.

Practical quick-start. Get the workup before supplementing. Comprehensive labs (CBC, ferritin, B12, folate, zinc, HbA1c, TSH) and dental/oral medicine evaluation. Correct any identified deficiency. For primary BMS after secondary causes ruled out: alpha-lipoic acid 200 mg TID for an 8–12 week trial. Switch to SLS-free toothpaste. Avoid known triggers. Discuss clonazepam swish-and-spit, topical capsaicin, or low-dose tricyclic with oral medicine / dental pain specialist if supplements alone are insufficient.

What to track

Pain intensity (NRS 0–10) and quality (burning, scalding, numb, paresthesia). Distribution (tongue dorsum, lateral tongue, lips, hard palate). Triggers and relievers. Sleep impact. Mood and anxiety. Diet impact / weight changes. Medications reviewed. Lab values trended (B12, ferritin, folate, zinc, HbA1c, TSH). Coordinate primary care, dental / oral medicine, and (where indicated) pain specialty.